REQUEST A DEMO
Total
USD $0.00
Search more companies

Kotra Pharma (M) Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kotra Pharma (M) Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Kotra Pharma (M) Sdn. Bhd. is based in Malaysia. The head office is in Melaka. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on September 15, 1982. There was a net sales revenue drop of 6.46% reported in Kotra Pharma (M) Sdn. Bhd.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 8.36%. Kotra Pharma (M) Sdn. Bhd.’s net profit margin decreased by 7.26% in 2024.

Headquarters
No. 1, 2 & 3, Jalan Ttc 12, Cheng Industrial Estate
Melaka; Malacca; Postal Code: 75250

Contact Details: Purchase the Kotra Pharma (M) Sdn. Bhd. report to view the information.

Website: http://www.kotrapharma.com

Basic Information
Registered Capital:
Purchase the Kotra Pharma (M) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Kotra Pharma (M) Sdn. Bhd. report to view the information.
Incorporation Date:
September 15, 1982
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Kotra Pharma (M) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-6.46%
Total operating revenue
-6.46%
Operating profit (EBIT)
-14.56%
EBITDA
6.6%
Net Profit (Loss) for the Period
-31.61%
Total assets
8.36%
Total equity
8.6%
Operating Profit Margin (ROS)
-2.37%
Net Profit Margin
-7.26%
Return on Equity (ROE)
-9.58%
Quick Ratio
-0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?